1-(3-((2-Hydroxy-3-methoxy-5-nitrobenzylidene)amino)phenyl)ethanone

Catalog No. :
ACTGKK063
CAS No. :
199992-27-3
Molecular Formula :
C16H14N2O5
Molecular Weight :
314.30

IUPAC Name:(E)-1-(3-((2-hydroxy-3-methoxy-5-nitrobenzylidene)amino)phenyl)ethan-1-one

1-(3-((2-Hydroxy-3-methoxy-5-nitrobenzylidene)amino)phenyl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-((2-Hydroxy-3-methoxy-5-nitrobenzylidene)amino)phenyl)ethanone
IUPAC Name(E)-1-(3-((2-hydroxy-3-methoxy-5-nitrobenzylidene)amino)phenyl)ethan-1-one
MDL No.MFCD00160899
Molecular FormulaC16H14N2O5
Molecular Weight314.30
SMILESCOC1=C(O)C(/C=N/C2=CC(C(C)=O)=CC=C2)=CC([N+](=O)[O-])=C1
InChI KeyAEJOSXXEFYMPAM-RQZCQDPDSA-N
Synonym3'-(2-HYDROXY-3-METHOXY-5-NITROBENZYLIDENEAMINO)ACETOPHENONE;Ethanone, 1-[3-[[(2-hydroxy-3-methoxy-5-nitrophenyl)methylene]amino]phenyl]-;3'-(2-HYDROXY-3-METHOXY-5-NITROBENZYLIDENEAMINO)ACETOPHENONE
CAS No.199992-27-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTGKK063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6 In Stock
  2. Plus
  3. ACRUTV285 route compound structure diagram
    ACRUTV28517028-61-4 In Stock
  4. Then
  5. ACTGKK063 route product structure diagram
    ACTGKK063199992-27-3
Inquiry

2. ACTGKK063 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDTG254 route compound structure diagram
    ACHDTG2542142-63-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGKK063 route product structure diagram
    ACTGKK063199992-27-3
Inquiry

Comments (0)